Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2006 by Aarhus University Hospital Skejby.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Aarhus University Hospital
Information provided by:
Aarhus University Hospital Skejby
ClinicalTrials.gov Identifier:
NCT00319293
First received: April 26, 2006
Last updated: October 10, 2006
Last verified: October 2006

April 26, 2006
October 10, 2006
Not Provided
Not Provided
  • Insulin resistance
  • Hormonal factors
  • Metabolic factors
Same as current
Complete list of historical versions of study NCT00319293 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome
Not Provided

Insulin resistance is an important feature of the polycystic ovary syndrome,and patiens are successfully treated with the insulin sensitizing agent metformin. The insulin resistance of lean patients with the syndrome is debated. In this study, we will study the change in insulin resistance, metabolic and hormonal factors after 3 months of metformin treatment in lean PCOS women.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Polycystic Ovary Syndrome
Drug: Metformin
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
20
Not Provided
Not Provided

Inclusion Criteria:

  • PCOS (Rotterdam criteria)
  • BMI < 27
  • No medication for 3 months

Exclusion Criteria:

  • Pregnancy
  • Lactation
  • Other endocrinologic disease
Female
20 Years to 35 Years
No
Not Provided
 
NCT00319293
160350-2
Not Provided
Not Provided
Aarhus University Hospital Skejby
Aarhus University Hospital
Principal Investigator: Birgitta Trolle, MD Skejby University Hospital
Aarhus University Hospital Skejby
October 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP